Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

(Reuters) -Novo Nordisk and Eli Lilly do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc, spokespeople for both companies said, rejecting a press release issued by the company on Thursday that described arrangements with the two leading drugmakers.

Spokespeople for both companies said in emails to Reuters that they had no special arrangements with the company.

Mangoceuticals did not respond to request for comment.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Shilpi Majumdar)

Source: Reuters.